Acology Management Confirms Great Start to 2016 in Letter to Shareholders

CORONA, CA--(Marketwired - Apr 26, 2016) - Acology Inc. (OTC PINK: ACOL)

• First Quarter Sales Triple
• New Product Agreements Near
• Expansion Continues in New Building
• Proprietary Printing Technology Unveiled
  
  

Dear Shareholders:

Our report for the first calendar quarter has been completed and we would like to confirm that sales of our signature product, The MedTainer™, have tripled estimates that we made at the end of 2015. We now confidently predict that our company will top the $2M mark in sales for the MedTainer alone. As promised before the end of this calendar quarter Acology Inc. is in the process of finalizing an agreement and will soon be offering new products to our more than 1500 national and global vendors. These products are intended to enhance the unique qualities of the MedTainer and allow our expansion to continue throughout the next three calendar quarters.

In addition, we have perfected a proprietary printing capability with the direct benefit of printing custom artwork, company logos and contact information on surfaces that were difficult or impossible to print. Working closely with Mimaki USA we now have installed and made operational a new, multi-capability, larger-format printer. Initially we looked for a printer that could give a much higher production capability than our current models. Mimaki USA provided an excellent custom-made solution for both capacity and flexibility. We believe that these capabilities and the solutions they represent to our vendor base will accomplish several different goals: Precise reproduction of artwork, multi-surface/size capability, triple production volume and increased sales. In addition, with the triple-volume of this new printer, backorders of printed products will be eliminated. This will increase our already excellent and highly-rated customer service reputation.

Acology's main purpose has always been to associate with excellent business partners that can move the proverbial needle. The early sales success of 2016, coupled with enhanced capabilities and product diversity, will create the proper environment for sustained growth for the remainder of this year and for the foreseeable future.

Please visit Acology Inc. and D&C Distributors online or by phone. The company is located in their production and distribution facility at 1620 Commerce St., Corona, California 92880.

Acology trades on the OTC under the call letters ACOL. The company's websites are www.Acologyinc.com for the hospice and palliative care industry and www.themedtainer.com for the recreational and medical marijuana industry. Orders for Acology products can be taken online and by phone. Custom orders are especially welcome. Please send any and all inquiries to info@acologyinc.com or call (844) ACOLOGY (844-226-5649)

This press release includes statements that are covered by the Private Securities Litigation Reform Act of 1995. Because such statements deal with future events they are subject to risks and uncertainties and actual results for fiscal year 2016 and beyond could differ materially from the company's current expectations. Forward-looking statements are identified by such words as "anticipates", "projects", "expects", "planned", "intends" and "believes", "estimate", "targets" and other similar expressions that indicate trends and future events. It is understood that investment entails risk on the part of the investor and could result in the loss of some or all of his or her investment.

Sincerely,

Acology Inc. Management Team